Freschia Gonzales

Freschia Gonzales

Freschia is a News Writer for Key Media, contributing to Wealth Professional and Benefits and Pensions Monitor. She has also contributed to Australasian Lawyer and NZ Lawyer. She graduated with a Bachelor of Arts, majoring in International Studies from the University of San Jose Recoletos.

Starting her writing career in 2021, she has produced content for international audiences. In her spare time, Freschia critiques movies and series, follows musicals, and keeps up with pop culture.

LinkedIn | Email

Canadian pension plans cap 2025 with solid gains despite fixed income drag

Equities and hedge funds offset bond losses in BNY pension universe

Canadian pension plans cap 2025 with solid gains despite fixed income drag

Canadians admit they do not know if their pension is DB or DC

Study shows advice gap as many workers lack plans, income targets and risk awareness

Canadians admit they do not know if their pension is DB or DC

Logistics in Northwestern Europe support Ontario university pensions

New mandate targets inflation-linked returns from Northwestern Europe industrial assets

Logistics in Northwestern Europe support Ontario university pensions

Calgary fintech raises $68.5 million to launch debut securitization with AIMCo, Northleaf

Neo Financial described the structure as a first of its kind for a Canadian fintech

Calgary fintech raises $68.5 million to launch debut securitization with AIMCo, Northleaf

Ottawa wants pension money in housing just as investors hit the exits

Pension funds weigh “de‑risked” affordable housing pitches against $30 billion locked in private property vehicles

Ottawa wants pension money in housing just as investors hit the exits

Big asset managers quietly bet inflation will outlast rate-cut hopes

BlackRock, Bridgewater and PIMCO reposition as "inflationary boom" risk builds

Big asset managers quietly bet inflation will outlast rate-cut hopes

Why Canadians worry more about their children’s retirement than their own

Survey finds most investors rely on advisors as family support erodes their own nest eggs

Why Canadians worry more about their children’s retirement than their own

New biosimilar eye drug promises to ease retinal cost pressures

New aflibercept biosimilar may ease retinal drug costs and help protect members' vision

New biosimilar eye drug promises to ease retinal cost pressures

Canadian materials and financials drive DB plans’ 2025 rebound

Pension portfolios lean on TSX surge as long bonds and U.S. dollar moves curb gains

Canadian materials and financials drive DB plans’ 2025 rebound

When tariffs make patients pay twice

Global trade fights squeeze drug access and budgets, adding pressure to already long wait times

When tariffs make patients pay twice